Your browser doesn't support javascript.
loading
Cancer immunotherapy: it's time to better predict patients' response.
Pilard, Charlotte; Ancion, Marie; Delvenne, Philippe; Jerusalem, Guy; Hubert, Pascale; Herfs, Michael.
  • Pilard C; Laboratory of Experimental Pathology, GIGA-Cancer, University of Liege, Liege, Belgium.
  • Ancion M; Laboratory of Experimental Pathology, GIGA-Cancer, University of Liege, Liege, Belgium.
  • Delvenne P; Laboratory of Experimental Pathology, GIGA-Cancer, University of Liege, Liege, Belgium.
  • Jerusalem G; Department of Pathology, University Hospital of Liege, Liege, Belgium.
  • Hubert P; Department of Medical Oncology, University Hospital of Liege, Liege, Belgium.
  • Herfs M; Laboratory of Experimental Pathology, GIGA-Cancer, University of Liege, Liege, Belgium.
Br J Cancer ; 125(7): 927-938, 2021 09.
Article en En | MEDLINE | ID: mdl-34112949

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inmunoterapia / Neoplasias Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inmunoterapia / Neoplasias Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article